Literature DB >> 6346107

Retroviral transforming genes in normal cells?

P H Duesberg.   

Abstract

The hallmark of retroviral transforming genes (onc genes) are specific sequences which are unrelated to essential virion genes but are closely related to sequences in normal cells. Viral onc genes probably originated from rare transductions of these cellular sequences by retroviruses without onc genes. Consequently, it has been suggested that retroviral transforming genes are present in normal cells in a latent form. However, recent structural analyses indicate that viral onc genes and cellular genes, which share specific sequences, are not isogenic. They differ from each other in scattered point mutations and in unique coding regions. The cellular genes containing onc-related sequences are expressed in normal cells compatible with a normal function. There is as yet no functional or consistent circumstantial evidence that these cellular genes cause cancer in animals that are not infected by viruses with onc genes. Therefore, it is still uncertain whether the onc-related cellular genes have oncogenic potential beyond their role as progenitors of retroviral onc genes.

Entities:  

Mesh:

Year:  1983        PMID: 6346107     DOI: 10.1038/304219a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  46 in total

1.  "Hopeful monsters," transposons, and Metazoan radiation.

Authors:  D H Erwin; J W Valentine
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

2.  Intermediate filament expression and lifespan potential in human somatic cell hybrids.

Authors:  C L Bunn; F A White; W M O'Guin; R H Sawyer; L W Knapp
Journal:  In Vitro Cell Dev Biol       Date:  1985-12

3.  Purification and properties of the Rous sarcoma virus internal enhancer binding factor.

Authors:  L Karnitz; D Poon; P A Weil; R Chalkley
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

Review 4.  Control of myogenic differentiation by cellular oncogenes.

Authors:  M D Schneider; E N Olson
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

5.  Platelet-derived growth factor agonist activity of a secreted form of the v-sis oncogene product.

Authors:  A Johnsson; C Betsholtz; K von der Helm; C H Heldin; B Westermark
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

Review 6.  Human oncogenes.

Authors:  K Willecke; R Schäfer
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

7.  Nucleotide sequence of avian carcinoma virus MH2: two potential onc genes, one related to avian virus MC29 and the other related to murine sarcoma virus 3611.

Authors:  N C Kan; C S Flordellis; G E Mark; P H Duesberg; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

8.  Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents.

Authors:  D F Bowen-Pope; A Vogel; R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  Expression of cellular oncogenes in primary cells from human acute leukemias.

Authors:  F Mavilio; N M Sposi; M Petrini; L Bottero; M Marinucci; G De Rossi; S Amadori; F Mandelli; C Peschle
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

Review 10.  Cancer models, genomic instability and somatic cellular Darwinian evolution.

Authors:  Mark P Little
Journal:  Biol Direct       Date:  2010-04-20       Impact factor: 4.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.